Skip to main content
SpringerLink
Log in

Neoplastic Skin Lesions in the Elderly Patient

Textbook of Aging Skin

  • 317 Accesses

Abstract

As the proportion of the elderly in the United States increases steadily, the costs of treating cutaneous disorders also rise. Proliferative disorders of the skin are particularly common in the aged, and the risk of malignancy increases with age with possible catastrophic consequences. Nonmalignant proliferative disorders (e.g., skin tags, seborrheic keratosis) are not likely to be fatal but can produce significant disfigurement and discomfort. The burden of benign skin neoplasms, when disfiguring, should be recognized, and older patients should be monitored by all their physicians for the development of potentially dangerous neoplastic disease, particularly the recognized precursor of squamous cell carcinoma, actinic keratosis, and the three cutaneous neoplasms that represent half of all skin cancers – basal cell carcinoma, squamous cell carcinoma, and melanoma. Newer therapies, particularly ones that target molecular and/or genetic pathways to carcinogenesis, are also improving patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Liao YH, Chen KH, Tseng MP, et al. Pattern of skin diseases in a geriatric patient group in Taiwan: a 7-year survey from the outpatient clinic of a university medical center. Dermatology. 2001;203:308–13.

    Article  CAS  PubMed  Google Scholar 

  2. Kligman AM, Koblenzer C. Demographics and psychological implications for the aging population. Dermatol Clin. 1997;15:549–53.

    Article  CAS  PubMed  Google Scholar 

  3. Fenske NA, Lober CW. Structural and functional changes of normal aging skin. J Am Acad Dermatol. 1986;15:571–85.

    Article  CAS  PubMed  Google Scholar 

  4. Bergfeld WF. The aging skin. Int J Fertil Womens Med. 1997;42:57–66.

    CAS  PubMed  Google Scholar 

  5. Seidler AM, Pennie ML, Veledar E, et al. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER) – Medicare data. Arch Dermatol. 2010;146:249–56.

    Article  PubMed  Google Scholar 

  6. Harvell JD, Maibach HI. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermatol. 1994;31:1015–21.

    Article  CAS  PubMed  Google Scholar 

  7. Webster GF. Common skin disorders in the elderly. Clin Cornerstone. 2001;4:39–44.

    Article  CAS  PubMed  Google Scholar 

  8. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3:395–401.

    Article  CAS  PubMed  Google Scholar 

  9. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681–90.

    Article  CAS  PubMed  Google Scholar 

  10. Gilchrest B, Krutmann J, editors. Skin aging. New York: Springer; 2006.

    Google Scholar 

  11. Lewis DA, Travers JB, Somani A, et al. The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene. 2010;29:1475–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Rass K, Reichrath J. Damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  13. de Gruijl FR, Van der Leun JC. Estimate of the wavelength dependency of ultraviolet carcinogenesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion. Health Phys. 1994;67:319–25.

    Article  PubMed  Google Scholar 

  14. Fields KA. Skin breakthroughs in the year 2000. Int J Fertil Womens Med. 2000;45:175–81.

    CAS  PubMed  Google Scholar 

  15. Rees JL. The genetics of sun sensitivity in humans. Am J Hum Genet. 2004;75:739–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Carless M, Griffiths L. Cytogenetics of melanoma and nonmelanoma skin cancer. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  17. Sarasin A. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res. 1999;428:5–10.

    Article  CAS  PubMed  Google Scholar 

  18. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol. 2004;195:298–308.

    Article  CAS  PubMed  Google Scholar 

  19. Emri G, Wenczl E, Van Erp P, et al. Low doses of UVB or UVA induce chromosomal aberrations in cultured human skin cells. J Invest Dermatol. 2000;115:435–40.

    Article  CAS  PubMed  Google Scholar 

  20. Domingo DS, Baron DB. Melanoma and nonmelanoma skin cancers and the immune system. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  21. Erb P, Ji J, Kump E, Mielgo A, Wernli M. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  22. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta. 1993;1155:181–205.

    CAS  PubMed  Google Scholar 

  23. Letier U, Garbe C, et al. Epidemiology of melanoma and nonmelanoma skin cancer – the role of sunlight. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  24. Filipowicz E, Adegboyega P, Sanchez RL, et al. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer. 2002;94:814–9.

    Article  CAS  PubMed  Google Scholar 

  25. Heckmann M, Zogelmeier F, Konz B. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure. Arch Dermatol. 2002;138:1494–7.

    Article  PubMed  Google Scholar 

  26. Auborn KJ. Carcinogenesis: current trends in skin cancer research. In: Zhai H, Wilhelm KP, Miabach H, editors. Marzulli and Maibach’s dermatotoxicology. Boca Raton: CRC Press LLC; 2008.

    Google Scholar 

  27. Addeo R, Napolitano A, Montella L, et al. Squamous cell carcinoma of the tongue in a female with advanced breast cancer: a case report of an elderly patient presenting with two types of cancer. Oncol Lett. 2014;8:235–7.

    PubMed Central  PubMed  Google Scholar 

  28. Heywood LA, Burke JF. Mismatch repair in mammalian cells. Bioessays. 1990;12:473–7.

    Article  CAS  PubMed  Google Scholar 

  29. Peltomäki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260:810–2.

    Article  PubMed  Google Scholar 

  30. Jaax S, Scott LW, Wolf JEJ, et al. General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutr Cancer. 1997;27:150–6.

    Article  CAS  PubMed  Google Scholar 

  31. Lamberg L. Diet may affect skin cancer prevention. JAMA. 1998;279:1427–8.

    Article  CAS  PubMed  Google Scholar 

  32. Davies TW, Treasure FP, Welch AA, et al. Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. Br J Dermatol. 2002;146:1017–22.

    Article  CAS  PubMed  Google Scholar 

  33. Tang JY, Parimi N, Wu A, et al. Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control. 2010;21:387–91.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Clark LC, Combs GFJ, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957–63.

    Article  CAS  PubMed  Google Scholar 

  35. Biliris KA, Koumantakis E, Dokianakis DN, et al. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett. 2000;161:83–8.

    Article  CAS  PubMed  Google Scholar 

  36. Bleiker TO, Graham-Brown RA. Diagnosing skin disease in the elderly. Practitioner. 2000;244:974–81.

    CAS  PubMed  Google Scholar 

  37. Carter DM, Balin AK. Dermatological aspects of aging. Med Clin N Am. 1983;67:531–43.

    CAS  PubMed  Google Scholar 

  38. Kelly R. Dermatoses in geriatric patients. Aust Fam Physician. 1977;6:36. 38-41, 43-4, PASSIM.

    CAS  PubMed  Google Scholar 

  39. Kleinsmith DM, Perricone NV. Common skin problems in the elderly. Dermatol Clin. 1986;4:485–99.

    CAS  PubMed  Google Scholar 

  40. Shelley WB, Shelley ED. The ten major problems of aging skin. Geriatrics. 1982;37:107–13.

    CAS  PubMed  Google Scholar 

  41. Spencer SK, Kierland RR. The aging skin: problems and their causes. Geriatrics. 1970;25:81–9.

    CAS  PubMed  Google Scholar 

  42. Lin AN, Carter DM, Balin AK. Nonmelanoma skin cancers in the elderly. Clin Geriatr Med. 1989;5:161–70.

    CAS  PubMed  Google Scholar 

  43. Keller KL, Fenske NA, Glass LF. Cancer of the skin in the older patient. Clin Geriatr Med. 1997;13:339–61.

    CAS  PubMed  Google Scholar 

  44. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a queensland community. J Invest Dermatol. 2000;115:273–7.

    Article  CAS  PubMed  Google Scholar 

  45. Bickle K, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician. 2002;65:1861–70.

    PubMed  Google Scholar 

  46. Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol. 2005;4:462–7.

    PubMed  Google Scholar 

  47. Chia A, Moreno G, Lim A, et al. Actinic keratoses. Aust Fam Physician. 2007;36:539–43.

    PubMed  Google Scholar 

  48. Cole HNJ. Skin tumors in the elderly. Postgrad Med. 1968;43:188–91.

    PubMed  Google Scholar 

  49. Lynch PJ. Tumors of the skin. Premalignment and malignant. Minn Med. 1974;57:780–7.

    CAS  PubMed  Google Scholar 

  50. Knox JM, Freeman RG. Diagnosis and treatment of skin tumors in the AGED. Geriatrics. 1967;22:143–55.

    CAS  PubMed  Google Scholar 

  51. Ericson MB, Wennberg A, Larkö O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008;4:1–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  52. Pollack SV. Skin cancer in the elderly. Clin Geriatr Med. 1987;3:715–28.

    CAS  PubMed  Google Scholar 

  53. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol. 2006;155:1262–9.

    Article  CAS  PubMed  Google Scholar 

  54. Ogbourne SM, Suhrbier A, Jones B, et al. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res. 2004;64:2833–9.

    Article  CAS  PubMed  Google Scholar 

  55. Hampson P, Kavanagh D, Smith E, et al. The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner. Cancer Immunol Immunother. 2008;57:1241–51.

    Article  CAS  PubMed  Google Scholar 

  56. Challacombe JM, Suhrbier A, Parsons PG, et al. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol. 2006;177:8123–32.

    Article  CAS  PubMed  Google Scholar 

  57. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012;66:486–93.

    Article  CAS  PubMed  Google Scholar 

  58. Lebwohl M, Swanson N, Anderson LL, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010–9.

    Article  CAS  PubMed  Google Scholar 

  59. Sligh JEJ. New therapeutic options for actinic keratosis and basal cell carcinoma. Sem Cutan Med Surg. 2014;33:S76–80.

    Article  Google Scholar 

  60. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA, International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56(1):125–43.

    Google Scholar 

  61. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat. 2003;14:99–106.

    Article  CAS  Google Scholar 

  62. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48:227–32.

    Article  PubMed  Google Scholar 

  63. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41–6.

    Article  CAS  PubMed  Google Scholar 

  64. Sandberg C, Stenquist B, Rosdahl I, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86:404–8.

    Article  PubMed  Google Scholar 

  65. Epstein E. Does intermittent “pulse” topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Am Acad Dermatol. 1998;38:77–80.

    Article  CAS  PubMed  Google Scholar 

  66. Urbach F. Ultraviolet radiation and skin cancer. In: Smith K, editor. Topics in photomedicine. Philadelphia: Plenum Press; 1984.

    Google Scholar 

  67. Gordon D, Siverstone H. Worldwide epidemiology of pre-malignant and malignant cutaneous lesions. In: Andrade R, editor. Cancer of the skin. Philadelphia: Saunders; 1976.

    Google Scholar 

  68. Hill D. Efficacy of sunscreens in protection against skin cancer. Lancet. 1999;354:699–700.

    Article  CAS  PubMed  Google Scholar 

  69. Ananthaswamy HN, Ullrich SE, Mascotto RE, et al. Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens. J Invest Dermatol. 1999;112:763–8.

    Article  CAS  PubMed  Google Scholar 

  70. Shuster S. Is sun exposure a major cause of melanoma? No. BMJ. 2008;337:a764.

    Article  PubMed  Google Scholar 

  71. Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33:1158–74.

    CAS  PubMed  Google Scholar 

  72. Gohara MA. Skin cancer in skins of color. J Drugs Dermatol. 2008;7:441–5.

    PubMed  Google Scholar 

  73. Helm K, Findeis-Hosey J. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A. J Cutan Pathol. 2008;35(10):931–4.

    Article  PubMed  Google Scholar 

  74. Cheretis C, Angelidou E, Dietrich F, et al. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma. Med Sci Monit. 2008;14:MT13–9.

    PubMed  Google Scholar 

  75. Peris K, Micantonio T, Piccolo D, et al. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges. 2007;5:970–6.

    Article  PubMed  Google Scholar 

  76. Eggermont AM, Voit C. Management of melanoma: a European perspective. Surg Oncol Clin N Am. 2008;17:635–48. x.

    Article  PubMed  Google Scholar 

  77. von Roenn JH, Kheir SM, Wolter JM, et al. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Cancer Res. 1986;46:3192–5.

    Google Scholar 

  78. Bikle DD. Vitamin D, receptor, UVR, and skin cancer: a potential protective mechanism. J Invest Dermatol. 2008;128:2357–61.

    Article  CAS  PubMed  Google Scholar 

  79. Shea CR, McNutt NS, Volkenandt M, et al. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol. 1992;141:25–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  80. Amstad PA, Cerutti PA. Ultraviolet-B-light-induced mutagenesis of C-H-ras codons 11 and 12 in human skin fibroblasts. Int J Cancer. 1995;63:136–9.

    Article  CAS  PubMed  Google Scholar 

  81. Urabe A, Nakayama J, Taniguchi S, et al. Expression of the fos oncogene in basal cell carcinoma. J Dermatol Sci. 1994;8:50–3.

    Article  CAS  PubMed  Google Scholar 

  82. Eshkoor SA, Ismail P, Rahman SA, et al. p16 gene expression in basal cell carcinoma. Arch Med Res. 2008;39:668–73.

    Article  CAS  PubMed  Google Scholar 

  83. Kim J, Modlin RL, Moy RL, et al. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol. 1995;155:2240–7.

    CAS  PubMed  Google Scholar 

  84. Goslen JB, Bauer EA. Basal cell carcinoma and collagenase. J Dermatol Surg Oncol. 1986;12:812–7.

    Article  CAS  PubMed  Google Scholar 

  85. Lear JT, Smith AG. Basal cell carcinoma. Postgrad Med J. 1997;73:538–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  86. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, et al. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol. 2007;157 Suppl 2:47–51.

    Article  CAS  PubMed  Google Scholar 

  87. Tierney L, McPhee S, Papadakis M. Current medical diagnosis and treatment. New York: McGraw Hill; 2000.

    Google Scholar 

  88. Stamp GW, Pignatelli M. Distribution of beta 1, alpha 1, alpha 2 and alpha 3 integrin chains in basal cell carcinomas. J Pathol. 1991;163:307–13.

    Article  CAS  PubMed  Google Scholar 

  89. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354:723–9.

    Article  CAS  PubMed  Google Scholar 

  90. Brash DE, Ziegler A, Jonason AS, et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc. 1996;1:136–42.

    CAS  PubMed  Google Scholar 

  91. Erbagci Z, Erkiliç S. Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role for peritumoral mast cells. Int J Dermatol. 2002;41:275–8.

    Article  PubMed  Google Scholar 

  92. Newman MD, Weinberg JM. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma. Cutis. 2007;79:18–28.

    PubMed  Google Scholar 

  93. Frisch M, Hjalgrim H, Olsen JH, et al. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med. 1996;125:815–21.

    Article  CAS  PubMed  Google Scholar 

  94. Thissen MRTM, Kuijpers DIM, Krekels GAM. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. J Drugs Dermatol. 2006;5:461–4.

    CAS  PubMed  Google Scholar 

  95. Wu JK, Oh C, Strutton G, et al. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma. Australas J Dermatol. 2006;47:46–8.

    Article  PubMed  Google Scholar 

  96. Spencer JM. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Dermatol Surg. 2006;32:63–9.

    Article  CAS  PubMed  Google Scholar 

  97. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361:1164–72.

    Article  Google Scholar 

  98. Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171–9.

    Article  CAS  PubMed  Google Scholar 

  99. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012;366:2180–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  100. Szeimies R, Gerritsen MP, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51:547–55.

    Article  PubMed  Google Scholar 

  101. Kennedy C, Bajdik CD, Willemze R, et al. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120:1087–93.

    Article  CAS  PubMed  Google Scholar 

  102. Garrett AB. Skin cancer in people of color. In: Snow N, Mikhail GR, editors. Mohs micrographic surgery. Madison: University of Wisconsion Press; 2004.

    Google Scholar 

  103. Mueller CS, Reichrath J. Histology of melanoma and nonmelanoma skin cancer. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  104. Akhdari N, Amal S, Ettalbi S. Bowen disease. CMAJ. 2006;175:739.

    Article  PubMed Central  PubMed  Google Scholar 

  105. Kossard S, Tan K, Choy C. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Am J Dermatopathol. 2008;30:127–34.

    Article  PubMed  Google Scholar 

  106. Gallagher RP. Sunscreens in melanoma and skin cancer prevention. CMAJ. 2005;173:244–5.

    Article  PubMed Central  PubMed  Google Scholar 

  107. Skin Cancer Foundation. Skin cancer facts: melanoma. http://www.skincancer.org/skin-cancer-information/skin-cancer-facts#melanoma. Accessed 19 Aug 2014.

  108. Manganoni AM, Pavoni L, Sereni E, et al. Role of occasional evaluation of the skin in early detection of melanoma in elderly patients. Indian J Dermatol Venereol Leprol. 2012;78:664.

    PubMed  Google Scholar 

  109. Giles GG, Armstrong BK, Burton RC, et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  110. McCartney RA. Malignant melanoma. In: Thackery E, editor. Gale encyclopedia of cancer. Farmington Hills: Thomson Gale Publishing; 2002.

    Google Scholar 

  111. Beers MH, Berkow BR. Dermatologic disorders: malignant tumors. In: Beers MH, Berkow R, editors. The Merck manual of diagnosis and therapy. Whitehouse Station: Merck Research Laboratories; 2002.

    Google Scholar 

  112. Rass K, Tilgen W. Treatment of melanoma and nonmelanoma skin cancer. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  113. Gillgren P, Brattström G, Frisell J, et al. Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations. Melanoma Res. 2005;15:125–32.

    Article  PubMed  Google Scholar 

  114. Cochran AJ, Elashoff D, Morton DL, et al. Individualized prognosis for melanoma patients. Hum Pathol. 2000;31:327–31.

    Article  CAS  PubMed  Google Scholar 

  115. Newman MD, Mirzabeigi M, Gerami P. Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod Pathol. 2009;22:1258–62.

    Article  CAS  PubMed  Google Scholar 

  116. Macdonald JB, Dueck AC, Gray RJ, et al. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer. 2011;2:538–43.

    Article  PubMed Central  PubMed  Google Scholar 

  117. Moan J, Porojnicu A, Dahlback A. Ultraviolet radiation and malignant melanoma. In: Reicharth J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Biosciences; 2008.

    Google Scholar 

  118. Menzies SW. Is sun exposure a major cause of melanoma? Yes. BMJ. 2008;337:a763.

    Article  PubMed  Google Scholar 

  119. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8–18.

    Article  CAS  PubMed  Google Scholar 

  120. Bulliard J, De Weck D, Fisch T, et al. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann Oncol. 2007;18:789–94.

    Article  PubMed  Google Scholar 

  121. Tsao H, Sober AJ. Ultraviolet radiation and malignant melanoma. Clin Dermatol. 1998;16:67–73.

    Article  CAS  PubMed  Google Scholar 

  122. Kraemer KH, Lee MM, Andrews AD, et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130:1018–21.

    Article  CAS  PubMed  Google Scholar 

  123. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005;32:191–205.

    Article  PubMed  Google Scholar 

  124. Armstrong BK, Kricker A. Skin cancer. Dermatol Clin. 1995;13:583–94.

    CAS  PubMed  Google Scholar 

  125. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988–93. Cancer Causes Control. 1997;8:246–52.

    Article  CAS  PubMed  Google Scholar 

  126. Garsaud P, Boisseau-Garsaud AM, Ossondo M, et al. Epidemiology of cutaneous melanoma in the French West Indies (Martinique). Am J Epidemiol. 1998;147:66–8.

    Article  CAS  PubMed  Google Scholar 

  127. Rolón PA, Kramárová E, Rolón HI, et al. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control. 1997;8:850–6.

    Article  PubMed  Google Scholar 

  128. Le Marchand L, Saltzman BS, Hankin JH, et al. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol. 2006;164:232–45.

    Article  PubMed  Google Scholar 

  129. Crombie IK. Variation of melanoma incidence with latitude in north America and Europe. Br J Cancer. 1979;40:774–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  130. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2005;14:562–6.

    Article  PubMed  Google Scholar 

  131. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid. Proc Natl Acad Sci U S A. 1989;86:8922–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  132. Garland CF, Garland FC, Gorham ED. Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. Ann Epidemiol. 1993;3:103–10.

    Article  CAS  PubMed  Google Scholar 

  133. Rivers JK. Is there more than one road to melanoma? Lancet. 2004;363:728–30.

    Article  PubMed  Google Scholar 

  134. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95:1878–90.

    Article  CAS  PubMed  Google Scholar 

  135. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14:7–17.

    CAS  PubMed  Google Scholar 

  136. Callen JP, Bickers DR, Moy RL. Actinic keratoses. J Am Acad Dermatol. 1997;36:650–3.

    Article  CAS  PubMed  Google Scholar 

  137. Kurban RS, Kurban AK. Common skin disorders of aging: diagnosis and treatment. Geriatrics. 1993;48:30–1. 35-6, 39-42.

    CAS  PubMed  Google Scholar 

  138. Gugić J, Strojan P. Squamous cell carcinoma of the head and neck in the elderly. Rep Pract Oncol Radiother. 2012;18:16–25.

    Article  PubMed Central  PubMed  Google Scholar 

  139. Gulati HK, Deshmukh SD, Anand M, et al. Low-grade malignant proliferating pilar tumor simulating a squamous-cell carcinoma in an elderly female: a case report and immunohistochemical study. Int J Trichol. 2011;3:98–101.

    Article  Google Scholar 

  140. Jung HJ, Jun JH, Kim HY, et al. Pigmented basal cell carcinoma of the nipple-areola complex in an elderly woman. Ann Dermatol. 2011;23:S201–4.

    Article  PubMed Central  PubMed  Google Scholar 

  141. Kanitakis J, Arbona-Vidal M, Faure E. Extensive pigmented vulvar basal-cell carcinoma presenting as pruritus in an elderly woman. Dermatol Online J. 2011;17:8.

    PubMed  Google Scholar 

  142. Corradin MT, Giulioni E, Fiorentino R, et al. In situ malignant melanoma on nevus spilus in an elderly patient. Acta Dermatovenerol Alpina Pannonica Adriat. 2014;23:17–9.

    Google Scholar 

  143. Berwick M. Counterpoint: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 2007;16:1923–4.

    Article  CAS  PubMed  Google Scholar 

  144. Xie J. Molecular biology of basal and squamous cell carcinomas. In: Reichrath J, editor. Sunlight, vitamin D and skin cancer. Austin: Landes Bioscience; 2008.

    Google Scholar 

  145. Wartman D, Weinstock M. Are we overemphasizing sun avoidance in protection from melanoma? Cancer Epidemiol Biomarkers Prev. 2008;17:469–70.

    Article  CAS  PubMed  Google Scholar 

  146. Wennberg AM, Lindholm LE, Alpsten M, et al. Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res. 1996;288:561–4.

    Article  CAS  PubMed  Google Scholar 

  147. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149:1242–9.

    Article  CAS  PubMed  Google Scholar 

  148. Loven K, Stein L, Furst K, et al. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther. 2002;24:990–1000.

    Article  CAS  PubMed  Google Scholar 

  149. Weiss J, Menter A, Hevia O, et al. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis. 2002;70:22–9.

    PubMed  Google Scholar 

  150. Wolf JEJ, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709–13.

    Article  CAS  PubMed  Google Scholar 

  151. Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146:94–100.

    Article  CAS  PubMed  Google Scholar 

  152. Fariba I, Ali A, Hossein SA, et al. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol. 2006;72:346–9.

    Article  PubMed  Google Scholar 

  153. Grimaître M, Etienne A, Fathi M, et al. Topical colchicine therapy for actinic keratoses. Dermatology. 2000;200:346–8.

    Article  PubMed  Google Scholar 

  154. Akar A, Bülent Taştan H, Erbil H, et al. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. J Dermatol Treat. 2001;12:199–203.

    Article  CAS  Google Scholar 

  155. Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol. 2002;138:1498–502.

    Article  CAS  PubMed  Google Scholar 

  156. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial. J Am Acad Dermatol. 2002;47:571–7.

    Article  PubMed  Google Scholar 

  157. Persaud AN, Shamuelova E, Sherer D, et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol. 2002;47:553–6.

    Article  PubMed  Google Scholar 

  158. Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50:714–21.

    Article  PubMed  Google Scholar 

  159. Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002–7.

    Article  CAS  PubMed  Google Scholar 

  160. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol. 2001;44:807–13.

    Article  CAS  PubMed  Google Scholar 

  161. Geisse JK, Rich P, Pandya A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol. 2002;47:390–8.

    Article  PubMed  Google Scholar 

  162. Sterry W, Ruzicka T, Herrera E, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol. 2002;147:1227–36.

    Article  CAS  PubMed  Google Scholar 

  163. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol. 2002;138:1165–71.

    Article  CAS  PubMed  Google Scholar 

  164. Spencer J. Actinic keratoses. http://www.emedicine.com/derm/topic9.htm. Accessed 18 Jan 2015.

  165. Ulrich C, Busch JO, Meyer T, et al. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. Br J Dermatol. 2006;155:451–4.

    Article  CAS  PubMed  Google Scholar 

  166. Ortonne J. From actinic keratosis to squamous cell carcinoma. Br J Dermatol. 2002;146 Suppl 61:20–3.

    Article  PubMed  Google Scholar 

  167. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions, and classification. J Invest Dermatol. 1994;102:4S–5.

    Article  CAS  PubMed  Google Scholar 

  168. Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol. 1994;102:6S–9.

    Article  CAS  PubMed  Google Scholar 

  169. Soehnge H, Ouhtit A, Ananthaswamy ON. Mechanisms of induction of skin cancer by UV radiation. Front Biosci. 1997;2:d538–51.

    CAS  PubMed  Google Scholar 

  170. Leman JA, McHenry PM. Basal cell carcinoma: still an enigma. Arch Dermatol. 2001;137:1239–40.

    Article  CAS  PubMed  Google Scholar 

  171. Moloney FJ, Comber H, O’Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006;154:498–504.

    Article  CAS  PubMed  Google Scholar 

  172. Zhang H, Ping XL, Lee PK, et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol. 2001;158:381–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  173. Scotto J, Fears TR, Fraumeni JF. Incidence of non-melanoma skin cancer in the United States. US Department of Health and Human Services, Bethesda MD: National Institutes of Health. 1983.

    Google Scholar 

  174. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin. 2000;50:215–36. quiz 237–40.

    Article  CAS  PubMed  Google Scholar 

  175. van der Pols JC, Williams GM, Pandeya N, et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev. 2006;15:2546–8.

    Article  PubMed  Google Scholar 

  176. Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155:771–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Winton Hill Business Center, The Procter & Gamble Company, 6110 Center Hill Avenue, Cincinnati, OH, 45224, USA

    Miranda A. Farage & Kenneth W. Miller

  2. San Gallicano Dermatological Institute, Rome, Italy

    Enzo Berardesca

  3. Department of Dermatology, University of California, 90 Medical Center Way, Surge 110, 0989, San Francisco, CA, 94143-0989, USA

    Howard I. Maibach & Isaac M. Neuhaus

Authors
  1. Miranda A. Farage
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enzo Berardesca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Howard I. Maibach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Isaac M. Neuhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miranda A. Farage .

Editor information

Editors and Affiliations

  1. Procter & Gamble Co., Cincinnati, Ohio, USA

    Miranda A. Farage

  2. Procter & Gamble Co., Cincinnati, Ohio, USA

    Kenneth W. Miller

  3. Department Dermatology, University of California, San Francisco School of Medicine, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Farage, M.A., Miller, K.W., Berardesca, E., Maibach, H.I., Neuhaus, I.M. (2015). Neoplastic Skin Lesions in the Elderly Patient. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27814-3_55-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27814-3_55-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27814-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Neoplastic Skin Lesions in the Elderly Patient
    Published:
    30 April 2016

    DOI: https://doi.org/10.1007/978-3-642-27814-3_55-3

  2. Original

    Neoplastic Skin Lesions in the Elderly Patient
    Published:
    23 July 2015

    DOI: https://doi.org/10.1007/978-3-642-27814-3_55-2

Search

Navigation